In humans, the mTOR-TP53BP1 fusion gene is easily observed in colorectal carcinoma, mammary neoplasm, ovarian carcinoma, and lung carcinoma and regulates PI3K/AKT/mTOR signaling pathway activation. This evidence concerns the gene AKT1 and ovarian carcinoma.